Drug overdose deaths decline in US amid political debate over fentanyl crisis

Sep 2, 2026

Drug overdose deaths in the United States fell by 27% in 2024 and continued to decline in 2025, driven by expanded naloxone distribution, prison treatment programs, and medication access. However, this progress faces political headwinds. Public health experts warn that looming Medicaid cuts and federal funding rollbacks under the Trump administration could reverse these gains, while House Republicans continue to investigate former Homeland Security Secretary Alejandro Mayorkas and the DEA over Biden-era border enforcement and fentanyl policies.

US overdose death decline

▪United States drug overdose deaths decreased by 27% in 2024, following a period from 2021 to 2023 where more than 105,000 people died from overdoses annually.
▪A Commonwealth Fund report published on September 3, 2026, suggests that the decline in overdose deaths is driven by a combination of public health initiatives rather than a single factor.
▪Drug overdose deaths decreased in every United States state in 2024 except for South Dakota, which recorded three more deaths than the previous year.
▪Preliminary data from 2025 indicate that drug overdose deaths in the United States have continued to decline, though overall overdose mortality remains high.

Naloxone distribution expansion

▪Virginia recorded a 40% decrease in drug overdose deaths from 2023 to 2024 after implementing a naloxone saturation plan.
▪In 2022, the federal Substance Abuse and Mental Health Services Administration mandated that states receiving opioid response funding develop a naloxone saturation plan.
▪Maryland more than doubled its naloxone distribution between 2021 and 2025 and experienced a 25% decrease in overdose deaths from 2019 to 2024.

Opioid use disorder medications

▪The Commonwealth Fund report identified Medicaid expansion as the single most influential lever for coverage and access to medications for opioid use disorders.
▪Sweden health authorities reported that a decade of concentrated expansion of access to opioid medications contributed to an approximate 25% reduction in deaths since 2017.
▪The number of methadone clinics in Colorado more than doubled from 25 to 54 over a five-year period, while New York saw similar growth.

Prison treatment programs

▪Substance use disorders are 12 times more common in the prison system than in the general population, making the weeks immediately following release especially risky.
▪The use of medications for opioid use disorder in New York prisons and jails increased seven times over between 2022 and 2025.

Border enforcement political debate

▪House Oversight Chair James Comer accused former Homeland Security Secretary Alejandro Mayorkas of allowing the Biden-era fentanyl crisis to occur due to poor border control.
▪Public health experts express concern that looming Medicaid cuts under the Trump administration could cause 156,000 people to lose access to opioid treatment.
▪The federal Substance Abuse and Mental Health Services Administration had more than half of its staff cut and roughly $1.7 billion in block grant funding canceled in the first year of the Trump administration.

Mayorkas fentanyl investigation

▪Attorney General Todd Blanche faces a September 14, 2026, deadline to produce Drug Enforcement Administration records requested by the House Oversight Committee.
▪Representative Melanie Stansbury supported a bipartisan inquiry but criticized House Oversight Chair James Comer for not consulting the ranking member, warning the probe reads as a partisan effort.
▪The House Oversight Committee opened an inquiry into Drug Enforcement Administration practices in New Mexico regarding the alleged monitoring rather than seizing of fentanyl shipments between 2023 and 2025.